|
| MDL 72527 Basic information |
Product Name: | MDL 72527 | Synonyms: | N,N'-di(buta-2,3-dien-1-yl)butane-1,4-diaMine;CPC-200;MDL 72527, >=97%;MDL 72527;N,N'-Bis(2,3-butadienyl)-1,4-butanediamine;N,N'-Bis(2,3-butanedienyl)-1,4-butanediamine;N1,N4-Bis(2,3-butadienyl)putrescine;N1,N4-DI(BUTA-2,3-DIENYL)BUTANE-1,4-DIAMINE DIHYDROCHLORIDE | CAS: | 93565-01-6 | MF: | C12H20N2.2HCl | MW: | 0 | EINECS: | | Product Categories: | | Mol File: | 93565-01-6.mol | |
| MDL 72527 Chemical Properties |
Melting point | 236-237 °C (decomp)(Solv: ethanol (64-17-5); ethyl acetate (141-78-6)) | storage temp. | Sealed in dry,2-8°C | solubility | H2O: soluble15mg/mL, clear | form | powder | color | light yellow to light brown |
Hazard Codes | Xi | Risk Statements | 36/37/38 | Safety Statements | 26 | WGK Germany | 3 |
| MDL 72527 Usage And Synthesis |
Uses | MDL 72527 is a lysosomotropic polyamineoxidase inhibitor. | Biological Activity | Polyamine oxidase (POA) inhibitor. Does not inhibit monoamine oxidase or D-Amino acid oxidase. Displays anticancer and neuroprotective activity in vivo . |
| MDL 72527 Preparation Products And Raw materials |
|